NATURE . COM {}

Matching Content Categories {📚}

• Education
• Social Networks
• Careers

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)

google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)

conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$63,100 per month
Our analysis indicates Nature.com generates between $42,042 and $115,616 monthly online from display ads.

Keywords {🔍}

nature, university, content, privacy, cookies, sign, drug, osaka, research, postdoctoral, data, science, advertising, policy, information, reviews, discovery, news, email, access, immunology, researcher, japan, california, merced, westlake, china, toronto, essential, optional, analysis, media, personal, parties, journals, journal, article, fda, nash, create, free, account, naturecom, continue, frontier, center, offers, positions, biochemistry, faculty,

Topics {✒️}

nature portfolio profit research-oriented university privacy policy advertising nature briefing social media nature personal data china access wendy schmidt ai data protection science postdoctoral fellowship multidisciplinary postdoctoral scholarships privacy journals search log tenured faculty position explore content selected content european economic area merced invites applications accepting optional cookies integrated science lab manage preferences content postdoctoral scholarships science news westlake university optional cookies article news email address choices essential cookies cookies skip free account biochemistry merced immunology california university osaka assistant science fellow biochemistry university varying standards rejected intercept obeticholic acid fibrosis due nonalcoholic steatohepatitis indication beset account continue google continue 1038/d41573-020-00126-9 jobs

Schema {🗺️}

WebPage:
      mainEntity:
         headline:FDA rejects NASH drug
         description:
         datePublished:2020-07-07T00:00:00Z
         dateModified:2020-07-07T00:00:00Z
         pageStart:501
         pageEnd:501
         sameAs:https://doi.org/10.1038/d41573-020-00126-9
         keywords:
            Biomedicine
            general
            Pharmacology/Toxicology
            Biotechnology
            Medicinal Chemistry
            Molecular Medicine
            Cancer Research
         image:
         isPartOf:
            name:Nature Reviews Drug Discovery
            volumeNumber:19
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Asher Mullard
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:FDA rejects NASH drug
      description:
      datePublished:2020-07-07T00:00:00Z
      dateModified:2020-07-07T00:00:00Z
      pageStart:501
      pageEnd:501
      sameAs:https://doi.org/10.1038/d41573-020-00126-9
      keywords:
         Biomedicine
         general
         Pharmacology/Toxicology
         Biotechnology
         Medicinal Chemistry
         Molecular Medicine
         Cancer Research
      image:
      isPartOf:
         name:Nature Reviews Drug Discovery
         volumeNumber:19
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Asher Mullard
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Reviews Drug Discovery
      volumeNumber:19
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Asher Mullard
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(4)

• https://www.facebook.com/NatureReviews
• https://twitter.com/NatRevDrugDisc
• https://twitter.com/intent/tweet?text=FDA+rejects+NASH+drug&url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41573-020-00126-9
• http://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.nature.com%2Farticles%2Fd41573-020-00126-9

External Links {🔗}(7)

• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Asher+Mullard each month?
• Find out how much https://scholar.google.co.uk/scholar?as_q=&btnG=Search+Scholar&as_sauthors=%22Asher%2BMullard%22 earns monthly
• Learn how profitable https://ir.interceptpharma.com/news-releases/news-release-details/intercept-receives-complete-response-letter-fda-obeticholic-acid is on a monthly basis
• What's the financial outcome of https://www.protocols.io/?
• Find out how much https://www.natureindex.com/ earns monthly
• http://www.naturechina.com's total income per month
• How much cash flow does https://www.natureasia.com/ja-jp have monthly?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref